CCL19/MIP-3 beta Antibody (RM0171-10J38) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-12098DL594
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Mouse
Applications
Block/Neutralize, Western Blot
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Monoclonal Rat IgG2 Clone # RM0171-10J38
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for CCL19/MIP-3 beta Antibody (RM0171-10J38) [DyLight 594]
Immunogen
Mouse recombinant CCL19/MIP-3 beta
Clonality
Monoclonal
Host
Rat
Isotype
IgG2
Applications for CCL19/MIP-3 beta Antibody (RM0171-10J38) [DyLight 594]
Application
Recommended Usage
Block/Neutralize
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CCL19/MIP-3 beta
Alternate Names
ELC, MIP-3 beta, MIP3 beta
Gene Symbol
CCL19
Additional CCL19/MIP-3 beta Products
Product Documents for CCL19/MIP-3 beta Antibody (RM0171-10J38) [DyLight 594]
Product Specific Notices for CCL19/MIP-3 beta Antibody (RM0171-10J38) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...